Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H25ClN2O4S.C4H4O4 |
Molecular Weight | 565.035 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C/C(O)=O.COC1=CC=C(C=C1)[C@@H]2SC3=C(C=CC(Cl)=C3)N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
InChI
InChIKey=FTUXVMVEKYLKGE-WECFPGDBSA-N
InChI=1S/C22H25ClN2O4S.C4H4O4/c1-14(26)29-20-21(15-5-8-17(28-4)9-6-15)30-19-13-16(23)7-10-18(19)25(22(20)27)12-11-24(2)3;5-3(6)1-2-4(7)8/h5-10,13,20-21H,11-12H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t20-,21+;/m1./s1
Molecular Formula | C22H25ClN2O4S |
Molecular Weight | 448.963 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Clentiazem is a chloride derivative of diltiazem, originated in Tanabe Seiyaku. It works as a blocker of calcium channels. The drug was investigated in the clinical trials for the treatment of stable angina, and essential hypertension. Despite the positive results of clinical trials, no development of the drug was reported.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Protective effects of the calcium antagonists diltiazem and TA3090 against hepatic injury due to hypoxia. | 1992 Dec 1 |
|
Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. | 1993 Jul |
|
Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in rat. | 2001 Oct |
|
Effects of first and second generation calcium channel blockers on diastolic function of the failing hamster heart: relationship with coronary flow changes. | 2003 Jul |
|
1,5-Benzothiazepine, a versatile pharmacophore: a review. | 2008 Nov |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:10:59 GMT 2023
by
admin
on
Sat Dec 16 05:10:59 GMT 2023
|
Record UNII |
YN4F0N5QE0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C169857
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL165667
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | |||
|
AA-81
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | |||
|
YN4F0N5QE0
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | |||
|
6435546
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | |||
|
m3616
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
96128-92-6
Created by
admin on Sat Dec 16 05:10:59 GMT 2023 , Edited by admin on Sat Dec 16 05:10:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |